{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:41:19Z","timestamp":1774716079867,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.transci.2025.104185","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T02:47:49Z","timestamp":1750387669000},"page":"104185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of heparin in autologous stem cell mobilization in patients with multiple myeloma"],"prefix":"10.1016","volume":"64","author":[{"given":"Ahmet","family":"Sarici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ali","family":"Erkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seda","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan","family":"Demircioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhami","family":"Berber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkadir","family":"Basturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Merter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Kuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Koroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emin","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Sinan","family":"Dal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdal","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turgay","family":"Ula\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevzi","family":"Altuntas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.transci.2025.104185_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.25791","article-title":"Multiple myeloma: 2020 update on diagnosis, risk-stratification and management","volume":"95","author":"Rajkumar","year":"2020","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.transci.2025.104185_bib2","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.5455\/annalsmedres.2021.01.098","article-title":"Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure","volume":"28","author":"Sarici","year":"2021","journal-title":"Ann Med Res"},{"issue":"9","key":"10.1016\/j.transci.2025.104185_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41408-020-00359-2","article-title":"Multiple myeloma current treatment algorithms","volume":"10","author":"Rajkumar","year":"2020","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.transci.2025.104185_bib4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/cancers14092277","article-title":"Improvement in post-autologous stem cell transplant survival of multiple myeloma patients: a long-term institutional experience","volume":"14","author":"Nunnelee","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.transci.2025.104185_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5455\/annalsmedres.2022.12.378","article-title":"The effect of CD 34+ stem cell dose on both short-term and long-term outcomes of autologous stem cell transplantation in multiple myeloma","volume":"30","author":"Uysal","year":"2023","journal-title":"Ann Med Res"},{"issue":"5","key":"10.1016\/j.transci.2025.104185_bib6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00277-023-05170-0","article-title":"Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments","volume":"102","author":"Wei","year":"2023","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.transci.2025.104185_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103159","article-title":"Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients","volume":"60","author":"Sarici","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.transci.2025.104185_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"10.1016\/j.transci.2025.104185_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.bmt.1705616","article-title":"Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?","volume":"39","author":"Cashen","year":"2007","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"10.1016\/j.transci.2025.104185_bib10","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1080\/10428190903096701","article-title":"Advances in mobilization for the optimization of autologous stem cell transplantation","volume":"50","author":"Vose","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.transci.2025.104185_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/bmt.2008.410","article-title":"Improving stem cell mobilization strategies: future directions","volume":"43","author":"Bensinger","year":"2009","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"10.1016\/j.transci.2025.104185_bib12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41409-024-02385-1","article-title":"Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma","volume":"59","author":"Avigan","year":"2024","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"10.1016\/j.transci.2025.104185_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199222050-00003","article-title":"Heparin pharmacokinetics and pharmacodynamics","volume":"22","author":"Kandrotas","year":"1992","journal-title":"Clin Pharm"},{"issue":"11","key":"10.1016\/j.transci.2025.104185_bib14","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1517\/14712598.8.11.1797","article-title":"Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells","volume":"8","author":"Uy","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.transci.2025.104185_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2141.2003.04107.x","article-title":"Mobilization of CD34 cells in elderly patients (\u2265 70 years) with multiple myeloma:: influence of age, prior therapy, platelet count and mobilization regimen","volume":"120","author":"Morris","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.transci.2025.104185_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.transci.2008.09.012","article-title":"Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients","volume":"39","author":"Mendrone","year":"2008","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.transci.2025.104185_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jca.21556","article-title":"Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation","volume":"33","author":"Moreb","year":"2018","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.transci.2025.104185_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jca.22079","article-title":"Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation","volume":"38","author":"Merter","year":"2023","journal-title":"J Clin Apher"},{"issue":"2","key":"10.1016\/j.transci.2025.104185_bib19","first-page":"249","article-title":"Heparin based anticoagulation during peripheral blood stem cell collection may increase the CD34+ cell yield","volume":"89","author":"Sevilla","year":"2004","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.transci.2025.104185_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103240","article-title":"An innovation in stem cell harvesting: Heparin use","volume":"60","author":"Gul","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.transci.2025.104185_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2017.03.031","article-title":"Heparin enhances CD34+ content of stem cells collected following G-CSF+\/-chemotherapy","volume":"19","author":"Merter","year":"2017","journal-title":"Cytotherapy"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225001223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225001223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T10:18:04Z","timestamp":1753352284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050225001223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1473050225001223"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2025.104185","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of heparin in autologous stem cell mobilization in patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2025.104185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104185"}}